1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 11 APRIL 2016

Cancer Drug News 11 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Highly Novel Therapies To Capitalise On China's Innovation Drive
Industry Brief - Patent Infringement Lawsuit Regarding Darzalex Filed In US
Industry Brief - EC Approves Giotrif To Treat Advanced SCC
Industry Brief - EC Approves Opdivo Expanded Use In NSCLC
Industry Brief - CHMP Recommends Inclusion Of New Data In EU Xtandi Label
Industry Brief - Opdivo Becomes First PD-1 Inhibitor Approved For RCC In EU
Industry Brief - Janssen/Tesaro Enter Worldwide Niraparib Licensing Deal For PCA
Industry Brief - First Patient Dosed In Avelumab/Inlyta Combination Trial
Industry Brief - Array BioPharma To Stop Binimetinib Phase III OC Trial
Industry Trend Analysis - Gilead Steps Up Drive For Transformation
Industry Brief - Xilonix Granted EMA Accelerated Assessment
Industry Brief - TAS-102 Phase III TERRA Study Meets Primary Endpoint In MCRC
Industry Brief - First Delcath Hepatic Chemosat Procedures Carried Out In Turkey
Industry Brief - Hikma, Lannett Gain Temolozomide Approvals
Industry Brief - EC Approves Gardasil 9 Two-Dose Schedule
Industry Brief - Eisai/PharmStandard Sign Cooperation Agreements In Russia
Industry Brief - MedImmune/Regeneron To Co-Develop ADCs To Treat Cancer
Industry Brief - CHMP Adopts Positive Opinion On Halaven/Opdivo+Yervoy Combination
Industry Brief - Apotex Launches Filgrastim Biosimilar
Industry Trend Analysis - GSK's Access Proposal Is Bold But Implementation Will Be Key
Industry Brief - Medigene Sells Partial Stake In Immunocore

Table Of Contents

Cancer Drug News 11 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.